Target intelligence / Profile preview

Novel transcript, antisense to phosphatidylinositol-specific phospholipase C X domain containing 3 (ENSG00000300736)

Target: ENSG00000300736
Molecular classification: Non-coding RNA, Antisense transcript

Overview

This entry refers to a novel antisense RNA transcript that overlaps with the gene encoding phosphatidylinositol-specific phospholipase C X domain containing 3 (PLCXD3). There is currently no experimental evidence supporting a protein product, druggability, or established role for this transcript in disease, therapy, or cellular function.

Beyond the preview

Go deeper on Novel transcript, antisense to phosphatidylinositol-specific phospholipase C X domain containing 3 (ENSG00000300736).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to phosphatidylinositol-specific phospholipase C X domain containing 3 (ENSG00000300736).

Explore the full profile